White blood cell count levels are associated with inflammatory response and constitute independent outcome predictors in adult patients with acute myeloid leukemia aged
American Journal of Hematology · 2024
DOI: 10.1002/ajh.27465 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Hematology, 2024. Verfasst von Michael Ozga und 14 weiteren Autor:innen. Beteiligte Einrichtung: The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Inflammation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: D Warren Brown Foundation, National Cancer Institute of the National Institutes of Health, Ohio Supercomputer Center and Shared Resources (Leukemia Tissue Bank).
Abstract (Originalsprache)
To the Editor:Acute myeloid leukemia (AML) is a biologically and clinically heterogenous disease with diverse genetic abnormalities 1-6 and a wide-ranging white blood cell counts (WBC) at diagnosis. 1 The 2022 European LeukemiaNet (ELN) genetic-risk classification incorporates cytogenetic and selected molecular alterations to define Favorable, Intermediate, and Adverse genetic-risk groups providing valuable prognostic information.1 Pretreatment WBC levels are also a main prognostic factor for patients with AML; 7,8 however, there are no standardized WBC-associated groups that improve prognostication for younger patients.de Jonge et al. 9 first investigated the impact of WBC on outcome of AML patients harboring NPM1 mutations and FLT3 internal tandem duplications (FLT3-ITD) that were divided into three WBC groups:
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA.
- Clara D. Bloomfield Center for Leukemia Outcomes Research, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA.
- Alliance Statistics and Data Center, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA.
- Department of Genetics, University of Alabama-Birmingham, Birmingham, Alabama, USA.
- Department of Medicine, University of Chicago, Chicago, Illinois, USA.
- Monter Cancer Center, Hofstra Northwell School of Medicine, Lake Success, New York, USA.
ORCID-Profile: Michael Ozga, Krzysztof Mrózek, James S Blachly
Förderung
- D Warren Brown Foundation
- National Cancer Institute of the National Institutes of Health
- Ohio Supercomputer Center and Shared Resources (Leukemia Tissue Bank)
- NCI NIH HHS
- Coleman Leukemia Research Foundation
- Pelotonia Fellowship Program
- Leukemia & Lymphoma Society Translational Research Grant
- Leukemia Research Foundation
Zitieren
APA
Ozga, M., Nicolet, D., Mrózek, K., Walker, C. J., Blachly, J. S., Kohlschmidt, J., Orwick, S., Carroll, A. J., Larson, R. A., Kolitz, J. E., Powell, B. L., Stone, R. M., Byrd, J. C., Eisfeld, A. K., & Mims, A. S. (2024). White blood cell count levels are associated with inflammatory response and constitute independent outcome predictors in adult patients with acute myeloid leukemia aged. American Journal of Hematology. https://doi.org/10.1002/ajh.27465
Vancouver
Ozga M, Nicolet D, Mrózek K, Walker CJ, Blachly JS, Kohlschmidt J, et al. White blood cell count levels are associated with inflammatory response and constitute independent outcome predictors in adult patients with acute myeloid leukemia aged. American Journal of Hematology. 2024. doi:10.1002/ajh.27465
BibTeX
@article{Ozga2024,
author = {Ozga, Michael and Nicolet, Deedra and Mrózek, Krzysztof and Walker, Christopher J and Blachly, James S and Kohlschmidt, Jessica and Orwick, Shelley and Carroll, Andrew J and Larson, Richard A and Kolitz, Jonathan E and Powell, Bayard L and Stone, Richard M and Byrd, John C and Eisfeld, Ann-Kathrin and Mims, Alice S},
title = {White blood cell count levels are associated with inflammatory response and constitute independent outcome predictors in adult patients with acute myeloid leukemia aged},
journal = {American Journal of Hematology},
year = {2024},
doi = {10.1002/ajh.27465}
}
EUVIMED